A Safety and Tolerability Study of INCB053914 in Combination With INCB050465 in Diffuse Large B-Cell Lymphoma
Status:
Completed
Trial end date:
2020-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and tolerability of INCB053914 in
combination with INCB050465 in relapsed or refractory diffuse large B-cell lymphoma (DLBCL).